Christopher Elles Clark

Christopher Elles Clark

Auto-generated profile, based on publicly available information

Christopher Elles Clark

University of Exeter Medical School, Exeter Collaboration for Academic Primary Care, Exeter, United Kingdom

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 October 2016 in British Journal of General Practice
Verified
Journal Article
Open access
PDF file
CCChristopher E Clark
Christopher E Clark
RTRod S Taylor
Rod S Taylor
ASAngela C Shore
Angela C Shore
JCJohn L Campbell
John L Campbell
Background Various prevalence figures have been reported for inter-arm differences in blood pressure (IAD); variation may be explained by differing population vascular risk and by measurement method. Aim To review the literature to derive robust estimates of IAD prevalence relevant to community populations. Design and setting Systematic review and meta-analysis. Method MEDLINE, Embase, and CINAHL were searched for cross-sectional studies likely to represent general or primary care populations, reporting prevalence of IAD and employing a simultaneous method of measurement. Using study-level data, pooled estimates of mean prevalence of systolic IADs were calculated and compared using a random effects model. Results Eighty IAD studies were identified. Sixteen met inclusion criteria: pooled estimates of prevalence for systolic IAD ≥10 mmHg were 11.2% (95% confidence interval [CI] = 9.1 to 13.6) in hypertension, 7.4% (95% CI = 5.8 to 9.2) in diabetes, and 3.6% (95% CI = 2.3 to 5.0) for a general adult population (P<0.001 for subgroup differences). Differences persisted for higher cut-off values. Prevalences were lower for East Asian than for Western populations and were overestimated by sequential measurement where this could be compared with simultaneous measurement within studies (relative risk for IAD: 2.9 [95% CI = 2.1 to 4.1]). Studies with higher mean absolute systolic pressures had higher prevalences for a systolic IAD ≥10 mmHg (P = 0.04). Conclusion Prevalences of IADs rise in relation to underlying cardiovascular comorbidities of the population studied, and are overestimated threefold when sequential measurement is used. Population-specific variation in prevalences of IAD should be taken into account in delivering clinical care and in planning future studies.

22 January 2021 in Journal of Human Hypertension
Verified
Journal Article
Open access
PDF file
CCChristopher E. Clark
Christopher E. Clark
SMSinead T. J. McDonagh
Sinead T. J. McDonagh
RMRichard J McManus
Richard J McManus
UMUna Martin
Una Martin

10 May 2014 in Diabetes Care
Verified
Journal Article
Open access
PDF file
CCChristopher E. Clark
Christopher E. Clark
ASAnna M. Steele
Anna M. Steele
RTRod S. Taylor
Rod S. Taylor
ASAngela C. Shore
Angela C. Shore
OUObioha C. Ukoumunne
Obioha C. Ukoumunne
JCJohn L. Campbell
John L. Campbell
OBJECTIVE: Differences in blood pressure between arms are associated with vascular disease and increased mortality; this has not been reported in diabetes. We explored these associations, and assessed reference standard and pragmatic measurement techniques, in people with diabetes and in nondiabetic controls. RESEARCH DESIGN AND METHODS: A prospective cohort study in Devon, England, recruited 727 people with type 1 or type 2 diabetes and 285 nondiabetic controls. Simultaneous repeated measurements of bilateral blood pressure were made at recruitment. Data were used to inform a pragmatic measurement strategy. Interarm differences were examined for cross-sectional associations with target organ disease and prospective mortality associations (median follow-up 52 months). RESULTS: We found 8.6% of participants with diabetes and 2.9% of controls had systolic interarm differences ≥10 mmHg. Single pairs of blood pressure measurements had high negative predictive values (97–99%) for excluding interarm differences. Systolic interarm differences ≥10 mmHg in diabetes were associated with peripheral arterial disease (odds ratio [OR] 3.4 [95% CI 1.2–9.3]). Differences ≥15 mmHg were associated with diabetic retinopathy (OR 5.7 [1.5–21.6]) and chronic kidney disease (OR 7.0 [1.7–29.8]). Systolic interarm differences were associated prospectively with increased cardiovascular mortality: hazard ratios 3.5 (1.0–13.0) for ≥10 mmHg and 9.0 (2.0–41.0) for ≥15 mmHg. CONCLUSIONS: Blood pressure should be measured in both arms during initial assessment in diabetes. Systolic interarm differences can be excluded with a single pair of measurements. In the population with diabetes, systolic differences may be associated with an increased risk of morbidity and mortality.

1 February 2021 in Hypertension
Verified
Journal Article
Open access
PDF file
CCChristopher E. Clark
Christopher E. Clark
FWFiona C Warren
Fiona C Warren
KBKate Boddy
Kate Boddy
SMSinead T.J. McDonagh
Sinead T.J. McDonagh
SMSarah F Moore
Sarah F Moore
JCJohn L. Campbell
John L. Campbell
Systolic interarm differences in blood pressure have been associated with all-cause mortality and cardiovascular disease. We undertook individual participant data meta-analyses to (1) quantify independent associations of systolic interarm difference with mortality and cardiovascular events; (2) develop and validate prognostic models incorporating interarm difference, and (3) determine whether interarm difference remains associated with risk after adjustment for common cardiovascular risk scores. We searched for studies recording bilateral blood pressure and outcomes, established agreements with collaborating authors, and created a single international dataset: the Inter-arm Blood Pressure Difference - Individual Participant Data (INTERPRESS-IPD) Collaboration. Data were merged from 24 studies (53 827 participants). Systolic interarm difference was associated with all-cause and cardiovascular mortality: continuous hazard ratios 1.05 (95% CI, 1.02–1.08) and 1.06 (95% CI, 1.02–1.11), respectively, per 5 mm Hg systolic interarm difference. Hazard ratios for all-cause mortality increased with interarm difference magnitude from a ≥5 mm Hg threshold (hazard ratio, 1.07 [95% CI, 1.01–1.14]). Systolic interarm differences per 5 mm Hg were associated with cardiovascular events in people without preexisting disease, after adjustment for Atherosclerotic Cardiovascular Disease (hazard ratio, 1.04 [95% CI, 1.00–1.08]), Framingham (hazard ratio, 1.04 [95% CI, 1.01–1.08]), or QRISK cardiovascular disease risk algorithm version 2 (QRISK2) (hazard ratio, 1.12 [95% CI, 1.06–1.18]) cardiovascular risk scores. Our findings confirm that systolic interarm difference is associated with increased all-cause mortality, cardiovascular mortality, and cardiovascular events. Blood pressure should be measured in both arms during cardiovascular assessment. A systolic interarm difference of 10 mm Hg is proposed as the upper limit of normal. Registration: URL: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42015031227

14 April 2016 in British Journal of General Practice
Verified
Journal Article
Open access
PDF file
CCChristopher E Clark
Christopher E Clark
RTRod S Taylor
Rod S Taylor
IBIsabella Butcher
Isabella Butcher
MSMarlene Cw Stewart
Marlene Cw Stewart
JPJackie Price
Jackie Price
JCJohn L Campbell
John L Campbell
Background: Differences in blood pressure between arms are associated with increased cardiovascular mortality in cohorts with established vascular disease or substantially elevated cardiovascular risk.Aim: To explore the association of inter-arm difference (IAD) with mortality in a community-dwelling cohort that is free of cardiovascular disease.Design and setting: Cohort analysis of a randomised controlled trial in central Scotland, from April 1998 to October 2008.Method: Volunteers from Lanarkshire, Glasgow, and Edinburgh, free of pre-existing vascular disease and with an ankle-brachial index ≤0.95, had systolic blood pressure measured in both arms at recruitment. Inter-arm blood pressure differences were calculated and examined for cross-sectional associations and differences in prospective survival. Outcome measures were cardiovascular events and all-cause mortality during mean follow-up of 8.2 years.Results: Based on a single pair of measurements, 60% of 3350 participants had a systolic IAD ≥5 mmHg and 38% ≥10 mmHg. An IAD ≥5 mmHg was associated with increased cardiovascular mortality (adjusted hazard ratio [HR] 1.91, 95% confidence interval [CI] = 1.19 to 3.07) and all-cause mortality (adjusted HR 1.44, 95% CI = 1.15 to 1.79). Within the subgroup of 764 participants who had hypertension, IADs of ≥5 mmHg or ≥10 mmHg were associated with both cardiovascular mortality (adjusted HR 2.63, 95% CI = 0.97 to 7.02, and adjusted HR 2.96, 95% CI = 1.27 to 6.88, respectively) and all-cause mortality (adjusted HR 1.67, 95% CI = 1.05 to 2.66, and adjusted HR 1.63, 95% CI = 1.06 to 2.50, respectively). IADs ≥15 mmHg were not associated with survival differences in this population.Conclusion: Systolic IADs in blood pressure are associated with increased risk of cardiovascular events, including mortality, in a large cohort of people free of pre-existing vascular disease.

31 March 2014 in British Journal of General Practice
Verified
Journal Article
Open access
PDF file
CCChristopher E Clark
Christopher E Clark
IHIsabella A Horvath
Isabella A Horvath
RTRod S Taylor
Rod S Taylor
JCJohn L Campbell
John L Campbell
Background The magnitude of the ‘white coat effect’, the alerting rise in blood pressure, is greater for doctors than nurses. This could bias interpretation of studies on nurse-led care in hypertension, and risks overestimating or overtreating high blood pressure by doctors in clinical practice. Aim To quantify differences between blood pressure measurements made by doctors and nurses. Design and setting Systematic review and meta-analysis using searches of MEDLINE, CENTRAL, CINAHL, Embase, journal collections, and conference abstracts. Method Studies in adults reporting mean blood pressures measured by doctors and nurses at the same visit were selected, and mean blood pressures extracted, by two reviewers. Study risk of bias was assessed using modified Cochrane criteria. Outcomes were pooled across studies using random effects meta-analysis. Results In total, 15 studies (11 hypertensive; four mixed hypertensive and normotensive populations) were included from 1899 unique citations. Compared with doctors’ measurements, nurse-measured blood pressures were lower (weighted mean differences: systolic −7.0 [95% confidence interval {CI} = −4.7 to −9.2] mmHg, diastolic −3.8 [95% CI = −2.2 to −5.4] mmHg). For studies at low risk of bias, differences were lower: systolic −4.6 (95% CI = −1.9 to −7.3) mmHg; diastolic −1.7 (95% CI = −0.1 to −3.2) mmHg. White coat hypertension was diagnosed more frequently based on doctors’ than on nurses’ readings: relative risk 1.6 (95% CI =1.2 to 2.1). Conclusions The white coat effect is smaller for blood pressure measurements made by nurses than by doctors. This systematic difference has implications for hypertension diagnosis and management. Caution is required in pooling data from studies using both nurse- and doctor-measured blood pressures.